Cardiac Stimulants and Depressants

advertisement

Chapter 17

Cardiac Stimulants and Depressants

The heart

Cardiac conduction p415

Autonomic innervation of the heart

Aspects of cardiac function affected by drugs p 415

Inotropic effects: force of contractions

Chronotropic effects: heart rate

Dromotropic effects: conduction of electrical impulses thru the myocardium

These effects can be positive or negative.

Heart failure p416

• Characterized by:

– Cardiac distention resulting from incomplete ventricle emptying

– Cardiac hypertrophy caused by heart’s adaptation to prolonged stretching (enlarged heart)

– Sodium and water

retention caused by, in part, diminished renal blood flow

Symptoms of heart failure p416

• Weight gain

• Peripheral edema

• Shortness of breath

• Pulmonary edema

Treatment of Heart Failure p416

• Cardiac glycosides: prototype: digoxin

(Lanoxin)

– Positive inotropic action

– Negative chronotropic action

– Negative dromotropic action

• Foxglove plant

Digoxin: Dose Considerations p416

• Long duration of action

• Method of administration

– Oral route most preferable

– Digitalizing dose IV

• To bring serum levels to a therapeutic level

• All glycosides have a low therapeutic index

Cardiac glycosides: Side Effects

• Gastrointestinal effects p 417,418

– Nausea and vomiting

– Anorexia

– Diarrhea

• Cardiac effects

– Cardiac arrhythmias

Cardiac glycosides: Toxicity p417,418

• Neurological effects

– Restlessness, confusion

– Irritability

– Drowsiness

– Vision changes

– Headache

Cardiac Glycoside Toxicity p418

• 10-20% of pt experience toxicity

• Predispose to cardiac glycoside toxicity:

– Hypokalemia

– Renal impairment

– Rapid IV administration

Cardiac Glycoside Toxicity p418

• Treatment

– Stop the drug

– Physical assessment

– Check potassium level

• Administer if needed

– Monitor heart rate

• Administer antiarrhythmics

• Digibind (digoxin immune fab)

– For life threatening toxicity

Nursing considerations when administering cardiac glycosides

• P 417 table 17-1

– Administer with meals if GI upset occurs

– Hold dose and report to PCP for HR < 60 bpm

– Hold dose and report for HR > 100 bpm

– Observe pt for signs of toxicity, document, report

– Monitor labs

– K+

– dig levels

Cardiac glycoside teaching

– Pt education

– teach pt to take radial pulse prior to taking his med

– instruct when to hold dose and contact physician

– instruct S/S dig toxicity

Antiarrhythmics and antidysrhythmics

Drug Action p419

• Obliterate or diminish rhythm disturbances:

– Decrease the automaticity in ectopic sites

– Alter dromotropic effects

– Alter the refractory period of cardiac muscle between consecutive contractions

Table 17-3 p425-428

• Antiarrhythmic drugs

– Monitor apical pulse for 1 minute prior to drug administration

– Record rate and rhythm

– Patient should be supine if IV drugs

Quinidine gluconate p420,

428

• Old antidysrhythmic agent

• Depressant of cardiac function

– Reduces the excitibility of cardiac muscle to electrical stimulation

– Negative chronotropic effect

• SA node regains control

Quinidine toxic effects p420

• Quinidine therapy is discontinued in 1/3 of pt due to toxic effects

– GI distress

– N&V

– anorexia

– diarrhea

– Cardiovascular disorders: hypotension, AV block

– Hypersensitivity

– tinnitus

– N&V

– headache

– dizziness

– impaired vision

– vertigo

– skin rashes

Procainamide (Pronestyl) p421,

427

• Cardiac effects are the same as quinidine, but procainamide has fewer adverse cardiovascular effects

• Pt that are allergic to “caine” local anesthetics may have a sensitivity to procainamide

Lidocaine (Xylocaine) p421,

426

• Widely used as a local anesthetic

• Has antidysrhythmic properties

• Drug of choice for treatment of premature ventricular contractions

(PVCs)

• Constant EKG monitoring is necessary for all pt during administration of lidocaine as an antidysrhythmic

Beta-adrenergic Blocking Agents

“beta blockers” (-olol) p423, 427

• Inhibit beta

1 and beta

2 sympathetic receptors

• Cardiac effects of beta blockers

• negative inotropic effect

• negative chronotropic effect

• negative dromotropic effect

• Decrease arrhythmias

• Decrease blood pressure

Beta-adrenergic blocking agents

• Adverse effects

– Cause bronchoconstriction

• Contraindications: pt with respiratory disease

– Cause heart failure

• Contraindications: pt with heart failure

• Examples

– Propanolol (Inderal) (prototype)

– Metoprolol (Lopresor)

– Atenolol (Tenormin)

Amiodarone HCL (Cordarone) p423

425

• Effective in treating dysrythmias

• Adverse effect: pulmonary toxicity

– Persistent nonproductive cough

– Chest pain with deep inhalation

– dyspnea

Calcium Channel Antagonists

“calcium channel blockers” p424, 428

• Reduces the influx of calcium into the cell

– relaxation of vascular smooth muscle

• Coronary artery dilation (treat angina)

• Reduction of myocardial oxygen consumption

• Lowered blood pressure

• Negative dromotropic effect

• Negative inotropic effect

• Example: verapamil (Calan) prototype

Drugs to treat shock p428

• Adrenergic

– Causes increase in heart rate

– Causes peripheral vasoconstriction

– Reverses hypotension from shock

• Anticholinergic

– Atropine sulfate

– Frequently given to treat bradycardia

Download